Halia Therapeutics, a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced six poster presentations and one oral presentation at the 67th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback